Skip to main content
DX
NYSE Real Estate & Construction

Dynex 10-Q: Q3 Loss of $1.34/Share, Book Value $10.91, New $350M Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: REIT Stocks · Real Estate
Sentiment info
Neutral
Importance info
7
Price
$10.82
Mkt Cap
$2.71B
52W Low
$10.31
52W High
$14.931
52W Position info
4.9% above low
Off High info
28% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

DX is trading near its 52-week low of $10.31 (4.9% above the low).

Summary

Dynex's Q3 10-Q restates the already-reported $1.34 per share loss and $10.91 book value, and adds a new authorization to repurchase up to $300 million of common and $50 million of preferred stock through April 2028.


Key Events · Earnings and Guidance · DX

  • New $350M Buyback Authorized

    The board approved repurchases of up to $300 million of common stock and up to $50 million of preferred stock through April 30, 2028, replacing the prior program that expired April 30, 2026. No shares were repurchased in Q3.

  • Q3 Loss Driven by Spread Widening

    Net loss to common shareholders was $338.3 million, or $1.34 per share, as unrealized losses on investments of $1.465 billion were only partly offset by $1.041 billion of gains on interest rate hedges.

  • Leverage and Liquidity Position

    Total assets were $27.9 billion against $24.2 billion of repurchase agreements at a 3.91% weighted average rate; leverage was 9.0x shareholders' equity and liquidity was approximately $1.3 billion.

  • Executive Contracts Amended

    Agreements with Byron L. Boston and Smriti L. Popenoe were amended October 27, 2026 to set base salary at $950,000, with a 12-month non-compete (24 months on a Change in Control separation) and perpetual confidentiality.


Analysis · DX · Real Estate & Construction

The Q3 loss itself is not new—those numbers were already public on October 19. What is new is the capital-allocation response: a board-authorized program to repurchase up to $300 million of common stock and up to $50 million of preferred stock through April 30, 2028, replacing a program that expired in April 2026. With book value at $10.91 per share and the stock trading near its 52-week low, that authorization gives management a stated tool to buy shares below book. The filing also confirms the balance-sheet scale behind the loss: $27.9 billion of assets funded by $24.2 billion of repo at a 3.91% weighted average rate, 9.0x leverage, and $1.3 billion of liquidity. Spread widening, not credit, drove the loss—unrealized losses on investments of $1.465 billion were partly offset by $1.041 billion of hedge gains, and no credit-loss allowance was recorded.

How filings like this one have moved

In the 30 days to Oct 27, 2026, 29.9% of the 1374 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DX was trading at $10.82 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $10.31 to $14.93. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DX - Latest Insights

DX
Oct 19, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.43
Real-time Price: $10.82 info
Change: +$0.390 (+4%) info
Market Cap: $2.71B info
DX
Oct 19, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $10.80
Real-time Price: $10.82 info
Change: +$0.020 (+0.19%) info
Market Cap: $2.71B info
DX
Sep 23, 2026, 5:04 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $11.80
Real-time Price: $10.82 info
Change: -$0.9792 (-8%) info
Market Cap: $2.71B info
DX
Sep 22, 2026, 5:25 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $12.13
Real-time Price: $10.82 info
Change: -$1.31 (-11%) info
Market Cap: $2.71B info
DX
Sep 22, 2026, 4:15 PM EDT
Filing Type: FWP
Importance Score:
7
Price at Filing: $12.09
Real-time Price: $10.82 info
Change: -$1.27 (-11%) info
Market Cap: $2.71B info